Correlation Between Bank Mandiri and Salarius Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Bank Mandiri and Salarius Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bank Mandiri and Salarius Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bank Mandiri Persero and Salarius Pharmaceuticals, you can compare the effects of market volatilities on Bank Mandiri and Salarius Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bank Mandiri with a short position of Salarius Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bank Mandiri and Salarius Pharmaceuticals.
Diversification Opportunities for Bank Mandiri and Salarius Pharmaceuticals
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Bank and Salarius is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Bank Mandiri Persero and Salarius Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Salarius Pharmaceuticals and Bank Mandiri is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bank Mandiri Persero are associated (or correlated) with Salarius Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Salarius Pharmaceuticals has no effect on the direction of Bank Mandiri i.e., Bank Mandiri and Salarius Pharmaceuticals go up and down completely randomly.
Pair Corralation between Bank Mandiri and Salarius Pharmaceuticals
Assuming the 90 days horizon Bank Mandiri is expected to generate 105.59 times less return on investment than Salarius Pharmaceuticals. But when comparing it to its historical volatility, Bank Mandiri Persero is 9.4 times less risky than Salarius Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Salarius Pharmaceuticals is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest 157.00 in Salarius Pharmaceuticals on October 22, 2024 and sell it today you would earn a total of 112.00 from holding Salarius Pharmaceuticals or generate 71.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bank Mandiri Persero vs. Salarius Pharmaceuticals
Performance |
| Timeline |
| Bank Mandiri Persero |
| Salarius Pharmaceuticals |
Bank Mandiri and Salarius Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bank Mandiri and Salarius Pharmaceuticals
The main advantage of trading using opposite Bank Mandiri and Salarius Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bank Mandiri position performs unexpectedly, Salarius Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salarius Pharmaceuticals will offset losses from the drop in Salarius Pharmaceuticals' long position.| Bank Mandiri vs. PT Bank Rakyat | Bank Mandiri vs. Piraeus Bank SA | Bank Mandiri vs. Eurobank Ergasias Services | Bank Mandiri vs. Zions Bancorporation |
| Salarius Pharmaceuticals vs. Akari Therapeutics PLC | Salarius Pharmaceuticals vs. Nutriband | Salarius Pharmaceuticals vs. SAB Biotherapeutics | Salarius Pharmaceuticals vs. GeoVax Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |